Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-060967
Filing Date
2024-05-16
Accepted
2024-05-16 14:13:56
Documents
16
Period of Report
2024-05-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A rkda-20240516.htm   iXBRL DEF 14A 1173536
2 GRAPHIC img70634337_0.jpg GRAPHIC 29171
3 GRAPHIC img70634337_1.jpg GRAPHIC 36397
4 GRAPHIC img70634337_2.jpg GRAPHIC 37577
5 GRAPHIC img70634337_3.jpg GRAPHIC 550316
6 GRAPHIC img70634337_4.jpg GRAPHIC 322498
  Complete submission text file 0000950170-24-060967.txt   4329030

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20240516.xsd EX-101.SCH 61919
19 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20240516_htm.xml XML 260708
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37383 | Film No.: 24954690
SIC: 0100 Agricultural Production-Crops
(CF Office: 08 Industrial Applications and Services)